Status:

UNKNOWN

The Effects of Dapagliflozin in Normal Clinical Practice in T2D

Lead Sponsor:

University of Milan

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

18+ years

Brief Summary

The aim of the study is to evaluate the benefits, documented in experimental settings, of treatment with Dapagliflozin in subjects with type 2 diabetes in normal clinical practice. The type of study ...

Detailed Description

An observational, multicentric, non-interventional, non-profit, single-arm, retrospective prospective study is proposed, aimed at investigating the therapeutic efficacy at 4 months of a treatment with...

Eligibility Criteria

Inclusion

  • Diagnosis of type II diabetes mellitus, according to ADA indications for at least 3 months
  • Males or females\> 18 years old
  • Stable therapy for at least 3 months with oral hypoglycemic agents / insulin
  • Prescription of Dapagliflozin®, according to normal clinical practice and local indications for the prescription / reimbursement of the drug.

Exclusion

  • Mental incapacity, unavailability or language barriers that preclude adequate understanding or cooperation;
  • Diagnosis of type 1 diabetes mellitus, maturity-onset diabetes of the young (MODY), latent autoimmune diabetes in adults (LADA), gestational diabetes mellitus, secondary diabetes mellitus or any other hyperglycemic state other than type 2 diabetes (T2D);
  • Women who are pregnant or breastfeeding, or women planning to become pregnant;
  • Previous participation in the study. Participation is defined by having given informed consent to the study;
  • Participation in another clinical study on T2D that includes any clinical intervention or administration of an investigational drug within 3 months prior to enrollment in the study;

Key Trial Info

Start Date :

June 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

1400 Patients enrolled

Trial Details

Trial ID

NCT05418946

Start Date

June 1 2022

End Date

December 1 2022

Last Update

June 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ASST FBF Sacco

Milan, Italy, 20157

The Effects of Dapagliflozin in Normal Clinical Practice in T2D | DecenTrialz